TTEK Stock Analysis: Tetra Tech | NASDAQ
Engineering & Construction | NASDAQ, USA | Market Cap: 9.074m USD | 12M Return: -4.1% | US88162G1031 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 86.4M
EPS Trend: -66.7%
Qual. Beats: 3
Rev. Trend: 98.4%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Tetra Tech (NASDAQ: TTEK) is a U.S.-headquartered consulting and engineering firm that provides technical services focused on water, the environment, and sustainable infrastructure for clients in the United States and abroad. The company operates through two segments: Government Services Group (GSG), which serves federal, state, local, and international development agencies, and Commercial/International Services Group (CIG), which serves commercial and international customers. Service offerings span water resource analysis, environmental monitoring, data analytics, civil infrastructure design, energy and greenhouse gas consulting, climate change advisory, and engineering design for specialized facilities such as data centers, laboratories, and disaster preparedness sites. Founded in 1966 and based in Pasadena, California, Tetra Tech has been publicly traded since its 1991 IPO.
As a member of the Industrials sector within the Environmental & Facilities Services sub-industry, Tetra Tech follows an asset-light, professional services business model in which revenue is generated primarily through billable consulting hours, engineering fees, and long-term government and commercial contracts rather than the sale of physical goods.
- Federal infrastructure funding accelerates Government Services backlog growth
- Water and environment consulting margins expand on federal contract mix shift
- Data center engineering demand surges from AI capacity buildout
| Net Income: 436.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 2.33 > 1.0 |
| NWC/Revenue: 4.85% < 20% (prev 5.30%; Δ -0.45% < -1%) |
| CFO/TA 0.13 > 3% & CFO 567.4m > Net Income 436.2m |
| Net Debt (1.02b) to EBITDA (659.8m): 1.54 < 3 |
| Current Ratio: 1.18 > 1.5 & < 3 |
| Outstanding Shares: last quarter (259.8m) vs 12m ago -3.11% < -2% |
| Gross Margin: 18.78% > 18% (prev 20.28%; Δ -1.50% > 0.5%) |
| Asset Turnover: 116.0% > 50% (prev 105.6%; Δ 10.35% > 0%) |
| Interest Coverage Ratio: 20.11 > 6 (EBIT TTM 602.0m / Interest Expense TTM 29.9m) |
| A: 0.06 (Total Current Assets 1.58b - Total Current Liabilities 1.33b) / Total Assets 4.39b |
| B: 0.45 (Retained Earnings 1.96b / Total Assets 4.39b) |
| C: 0.14 (EBIT TTM 602.0m / Avg Total Assets 4.37b) |
| D: 0.73 (Book Value of Equity 1.85b / Total Liabilities 2.54b) |
| Altman-Z'' = 3.51 = A |
| DSRI: 0.77 (Receivables 1.08b/1.27b, Revenue 5.07b/4.60b) |
| GMI: 1.08 (GM 20.28% / 18.78%) |
| AQI: 1.02 (AQ_t 0.58 / AQ_t-1 0.57) |
| SGI: 1.10 (Revenue 5.07b / 4.60b) |
| TATA: -0.03 (NI 436.2m - CFO 567.4m) / TA 4.39b) |
| Beneish M = -3.06 (Cap -4..+1) = AA |
As of August 11, 2026, the stock is trading at USD 35.04 with a total of 2,643,895 shares traded. Over the past week, the price has changed by +3.58%, over one month by +13.07%, over three months by +18.73% and over the past year by -4.07%.
Current recommended Stop Loss: 33.60 (which is 4.1% or 1.3 ATR below the current price).
Tetra Tech has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy TTEK.
- StrongBuy: 3
- Buy: 2
- Hold: 3
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 40.3 | 15.1% |
P/E Trailing = 21.3494
P/E Forward = 20.2429
P/S = 2.0819
P/B = 4.8995
P/EG = 2.0954
Revenue TTM = 5.07b USD
EBIT TTM = 602.0m USD
EBITDA TTM = 659.8m USD
Long Term Debt = 801.1m USD (from longTermDebt, last quarter)
Short Term Debt = 74.7m USD (from shortTermDebt, last quarter)
Debt = 1.25b USD (from shortLongTermDebtTotal, last quarter) + Leases 222.4m
Net Debt = 1.02b USD (calculated: Debt 1.25b - CCE 230.8m)
Enterprise Value = 10.1b USD (9.07b + Debt 1.25b - CCE 230.8m)
Interest Coverage Ratio = 20.11 (Ebit TTM 602.0m / Interest Expense TTM 29.9m)
EV/FCF = 18.40x (Enterprise Value 10.1b / FCF TTM 548.2m)
FCF Yield = 5.43% (FCF TTM 548.2m / Enterprise Value 10.1b)
FCF Margin = 10.81% (FCF TTM 548.2m / Revenue TTM 5.07b)
Net Margin = 8.60% (Net Income TTM 436.2m / Revenue TTM 5.07b)
Gross Margin = 18.78% ((Revenue TTM 5.07b - Cost of Revenue TTM 4.12b) / Revenue TTM)
Gross Margin QoQ = 18.59% (prev 17.55%)
Tobins Q-Ratio = 2.30 (Enterprise Value 10.1b / Total Assets 4.39b)
Interest Expense / Debt = 2.40% (Interest Expense 29.9m / Debt 1.25b)
Taxrate = 26.54% (157.7m / 594.2m)
NOPAT = 442.2m (EBIT 602.0m * (1 - 26.54%))
Current Ratio = 1.18 (Total Current Assets 1.58b / Total Current Liabilities 1.33b)
Debt / Equity = 0.67 (Debt 1.25b / totalStockholderEquity, last quarter 1.85b)
Debt / EBITDA = 1.54 (Net Debt 1.02b / EBITDA 659.8m)
Debt / FCF = 1.85 (Net Debt 1.02b / FCF TTM 548.2m)
Total Stockholder Equity = 1.84b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.98% (Net Income 436.2m / Total Assets 4.39b)
RoE = 23.76% (Net Income TTM 436.2m / Total Stockholder Equity 1.84b)
RoCE = 22.83% (EBIT 602.0m / Capital Employed (Equity 1.84b + L.T.Debt 801.1m))
RoIC = 15.26% (NOPAT 442.2m / Invested Capital 2.90b)
WACC = 6.61% (E(9.07b)/V(10.3b) * Re(7.27%) + D(1.25b)/V(10.3b) * Rd(2.40%) * (1-Tc(0.27)))
Discount Rate = 7.27% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -90.32 | Cagr: -1.60%
[DCF] Terminal Value 77.97% ; FCFF base≈506.0m ; Y1≈580.0m ; Y5≈853.6m
[DCF] Fair Price = 46.20 (EV 12.8b - Net Debt 1.02b = Equity 11.8b / Shares 256.0m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -66.69 | EPS CAGR: -19.23% | SUE: 1.20 | # QB: 3
Revenue Correlation: 98.43 | Revenue CAGR: 10.26% | SUE: 0.60 | # QB: 0
EPS current Quarter (2026-12-31): EPS=0.38 | Chg30d=+0.66% | Revisions=-40% | Analysts=4
EPS current Year (2026-09-30): EPS=1.58 | Chg30d=+2.21% | Revisions=+25% | GrowthEPS=+1.1% | GrowthRev=-5.7%
EPS next Year (2027-09-30): EPS=1.74 | Chg30d=+1.29% | Revisions=-25% | GrowthEPS=+10.2% | GrowthRev=+4.3%
[Analyst] Revisions Ratio: -29% (up=1, down=3)